Petia Mitchell

555 total citations
13 papers, 380 citations indexed

About

Petia Mitchell is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Petia Mitchell has authored 13 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Petia Mitchell's work include Cancer, Hypoxia, and Metabolism (8 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Virus-based gene therapy research (4 papers). Petia Mitchell is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Virus-based gene therapy research (4 papers). Petia Mitchell collaborates with scholars based in United States, United Kingdom and China. Petia Mitchell's co-authors include Pedro J. Beltran, Elaina Cajulis, Frank J. Calzone, Robert Radinsky, Richard Kendall, Steven Vonderfecht, Brian Belmontes, Gordon Moody, John Lu and Joanne Ho and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Petia Mitchell

13 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Petia Mitchell United States	8	194	185	131	92	75	13	380
Xingyun Su China	11	161 0.8×	77 0.4×	186 1.4×	53 0.6×	79 1.1×	20	401
Ivo Marchetti Italy	12	125 0.6×	161 0.9×	316 2.4×	68 0.7×	48 0.6×	20	522
О. С. Ларін United States	11	339 1.7×	278 1.5×	420 3.2×	87 0.9×	117 1.6×	32	727
Tomasz Tyszkiewicz Poland	11	180 0.9×	70 0.4×	86 0.7×	30 0.3×	99 1.3×	20	319
Bangbo Zhao China	14	205 1.1×	147 0.8×	45 0.3×	25 0.3×	127 1.7×	43	435
Nita Williams United States	9	274 1.4×	146 0.8×	29 0.2×	67 0.7×	97 1.3×	23	461
René Scheiden Luxembourg	10	100 0.5×	138 0.7×	38 0.3×	47 0.5×	51 0.7×	27	336
M A A Al-Rawi United Kingdom	9	144 0.7×	220 1.2×	36 0.3×	18 0.2×	36 0.5×	9	375
Eleonora Zanetti Italy	10	77 0.4×	80 0.4×	55 0.4×	25 0.3×	31 0.4×	29	253
Javier Aller Pardo Spain	4	94 0.5×	131 0.7×	253 1.9×	95 1.0×	15 0.2×	4	331

Countries citing papers authored by Petia Mitchell

Since Specialization

Citations

This map shows the geographic impact of Petia Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petia Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petia Mitchell more than expected).

Fields of papers citing papers by Petia Mitchell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petia Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petia Mitchell. The network helps show where Petia Mitchell may publish in the future.

Co-authorship network of co-authors of Petia Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Petia Mitchell. A scholar is included among the top collaborators of Petia Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petia Mitchell. Petia Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Estrada, Juan, Jinghui Zhan, Petia Mitchell, et al.. (2023). OncoVEX^mGM-CSFexpands tumor antigen-specific CD8+ T-cell response in preclinical models. Journal for ImmunoTherapy of Cancer. 11(5). e006374–e006374. 8 indexed citations

Moesta, Achim K., Keegan S. Cooke, Julia Piasecki, et al.. (2017). Local Delivery of OncoVEXmGM-CSF Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte–Associated Protein Blockade. Clinical Cancer Research. 23(20). 6190–6202. 81 indexed citations

Cooke, Keegan S., Juan Estrada, Jinghui Zhan, et al.. (2016). Abstract 2351: Development of a B16F10 cell line expressing mNectin1 to study the activity of OncoVEXmGM-CSF in murine syngeneic melanoma models. Cancer Research. 76(14_Supplement). 2351–2351. 4 indexed citations

Cooke, Keegan S., et al.. (2015). Innate and adaptive immunity contribute to the anti-tumor mechanisms of action of OncoVEXmGM-CSF. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). P338–P338. 3 indexed citations

Cooke, Keegan S., James B. Rottman, Jinghui Zhan, et al.. (2015). Oncovex MGM-CSF –mediated regression of contralateral (non-injected) tumors in the A20 murine lymphoma model does not involve direct viral oncolysis. Journal for ImmunoTherapy of Cancer. 3(S2). 7 indexed citations

Beltran, Pedro J., Frank J. Calzone, Petia Mitchell, et al.. (2014). Ganitumab (AMG 479) Inhibits IGF-II–Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy. Clinical Cancer Research. 20(11). 2947–2958. 41 indexed citations

Moody, Gordon, Pedro J. Beltran, Petia Mitchell, et al.. (2014). IGF1R blockade with ganitumab results in systemic effects on the GH–IGF axis in mice. Journal of Endocrinology. 221(1). 145–155. 19 indexed citations

Calzone, Frank J., Elaina Cajulis, Petia Mitchell, et al.. (2013). Epitope-Specific Mechanisms of IGF1R Inhibition by Ganitumab. PLoS ONE. 8(2). e55135–e55135. 28 indexed citations

Beltran, Pedro J., Gordon Moody, Petia Mitchell, et al.. (2011). Efficacy of Ganitumab (AMG 479), Alone and in Combination with Rapamycin, in Ewing’s and Osteogenic Sarcoma Models. Journal of Pharmacology and Experimental Therapeutics. 337(3). 644–654. 65 indexed citations

10.

Beltran, Pedro J., Petia Mitchell, Elaina Cajulis, et al.. (2009). AMG 479, a fully human anti–insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells. Molecular Cancer Therapeutics. 8(5). 1095–1105. 113 indexed citations

11.

Beltran, Pedro J., Petia Mitchell, Elaina Cajulis, et al.. (2009). Abstract C172: Efficacy of AMG 479, alone and in combination with cisplatin, in ovarian carcinoma xenograft models. Molecular Cancer Therapeutics. 8(12_Supplement). C172–C172. 1 indexed citations

12.

Beltran, Pedro J., Petia Mitchell, David Hwang, et al.. (2007). Inhibition of endocrine IGF-1 signaling in normal murine tissues and human tumor xenografts with AMG 479, a fully human anti IGF-1R monoclonal antibody. Molecular Cancer Therapeutics. 6. 4 indexed citations

13.

Moody, Gordon, Petia Mitchell, Elaina Cajulis, et al.. (2007). AMG 479, a fully human anti IGF-1 receptor monoclonal antibody, is efficacious against Ewing’s sarcoma and osteosarcoma xenografts. Molecular Cancer Therapeutics. 6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact